Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amosartan vs Cozaar Plus Pro in Essential Hypertension
NCT01828359Phase 4Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Aug 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Amosartan in essential hypertension, sponsored by Hanmi Pharmaceutical. Started Aug 2010; status: completed.
02
Drugs
Amosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01828359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828359.